Department of Intensive Care, Erasme University Hospital, Unversité Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.
Klinik für Anästhesiologie und operative Intensivmedizin, Klinikum Augsburg, Augsburg, Germany.
Crit Care. 2018 Apr 19;22(1):102. doi: 10.1186/s13054-018-2018-9.
The aim was to describe transfusion practice in critically ill patients at an international level and evaluate the effects of red blood cell (RBC) transfusion on outcomes in these patients.
This was a pre-planned sub-study of the Intensive Care Over Nations audit, which involved 730 ICUs in 84 countries and included all adult patients admitted between 8 May and 18 May 2012, except admissions for routine postoperative surveillance.
ICU and hospital outcomes were recorded. Among the 10,069 patients included in the audit, data related to transfusion had been completed for 9553 (mean age 60 ± 18 years, 60% male); 2511 (26.3%) of these had received a transfusion, with considerable variation among geographic regions. The mean lowest hemoglobin on the day of transfusion was 8.3 ± 1.7 g/dL, but varied from 7.8 ± 1.4 g/dL in the Middle East to 8.9 ± 1.9 g/dL in Eastern Europe. Hospital mortality rates were higher in transfused than in non-transfused patients (30.0% vs. 19.6%, p < 0.001) and increased with increasing numbers of transfused units. In an extended Cox proportional hazard analysis, the relative risk of in-hospital death was slightly lower after transfusion in the whole cohort (hazard ratio 0.98, confidence interval 0.96-1.00, p = 0.048). There was a stepwise decrease in the hazard ratio for mortality after transfusion with increasing admission severity scores.
More than one fourth of critically ill patients are transfused during their ICU stay, with considerable variations in transfusion practice among geographic regions. After adjustment for confounders, RBC transfusions were associated with a slightly lower relative risk of in-hospital death, especially in the most severely ill patients, highlighting the importance of taking the severity of illness into account when making transfusion decisions.
本研究旨在描述国际范围内危重症患者的输血实践,并评估红细胞(RBC)输血对这些患者结局的影响。
这是 Intensive Care Over Nations 审计的一项预先计划的子研究,该研究纳入了 84 个国家的 730 个 ICU,纳入了 2012 年 5 月 8 日至 18 日期间除常规术后监测外入住的所有成年患者。
记录了 ICU 和住院结局。在该审计纳入的 10069 例患者中,有 9553 例(平均年龄 60±18 岁,60%为男性)完成了输血相关数据;其中 2511 例(26.3%)接受了输血,不同地理区域之间存在显著差异。输血当天的最低血红蛋白均值为 8.3±1.7 g/dL,但从中东的 7.8±1.4 g/dL 到东欧的 8.9±1.9 g/dL 不等。输血患者的住院死亡率高于未输血患者(30.0% vs. 19.6%,p<0.001),且随输血量的增加而升高。在扩展的 Cox 比例风险分析中,整个队列输血后院内死亡的相对风险略有降低(风险比 0.98,95%置信区间 0.96-1.00,p=0.048)。随着入院严重程度评分的增加,输血后死亡的风险比呈逐步下降趋势。
超过四分之一的危重症患者在 ICU 期间接受输血,不同地理区域之间的输血实践存在显著差异。在校正混杂因素后,RBC 输血与院内死亡的相对风险略有降低相关,尤其是在病情最严重的患者中,这凸显了在做出输血决策时考虑疾病严重程度的重要性。